TScan Therapeutics Inc. (TCRX)
NASDAQ: TCRX
· Real-Time Price · USD
1.80
-0.01 (-0.55%)
At close: Aug 15, 2025, 3:59 PM
1.80
-0.28%
After-hours: Aug 15, 2025, 04:10 PM EDT
TScan Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 169.39M | 154.11M | 178.69M | 133.12M | 242.16M | 140.51M | 133.36M | 155.19M | 208.84M | 95.61M | 120.03M | 137.31M | 125.6M | 140.84M | 161.41M | 182.31M | 106.2M | 121.5M |
Short-Term Investments | 48.65M | 97.58M | 111.42M | 138M | 55.52M | 22.27M | 58.69M | 60.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 5.03M | 5.03M | 5.03M | 5.03M | 5.03M | 5.04M | n/a | 5.04M | 5.03M | 5.2M | 595K | 595K | 761K |
Other Long-Term Assets | 6.81M | 6.79M | 6.8M | 6.84M | 6.78M | 1.65M | 1.65M | 64.02M | 35.02M | 6M | 4.83M | 9.57M | 2.46M | 1.61M | n/a | 166K | 2.71M | 1.12M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 31.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -33.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.08M | 3.15M | 2.61M | 2.96M | 1.85M | 1.94M | 2.19M | 2.14M | 1.45M | n/a | 4.1M | n/a | 3.76M | 4.91M | 4.25M | 4.69M | 3.87M | n/a |
Total Current Assets | 221.13M | 254.84M | 292.72M | 274.08M | 299.53M | 164.72M | 194.24M | 155.19M | 208.84M | 95.61M | 120.03M | 141.18M | 129.36M | 145.75M | 165.65M | 187M | 110.07M | 123.87M |
Property-Plant & Equipment | 70.62M | 71.09M | 71.6M | 67.1M | 68.56M | 69.43M | 71.23M | 67.13M | 68.03M | 66.93M | 69.2M | 14.7M | 15.55M | 15.81M | 17.26M | 17.13M | 16.64M | 15.18M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 77.43M | 77.87M | 78.4M | 73.94M | 75.34M | 76.11M | 77.91M | 136.19M | 108.08M | 77.97M | 79.06M | 24.28M | 23.05M | 22.45M | 22.45M | 17.89M | 19.94M | 17.07M |
Total Assets | 298.56M | 332.71M | 371.12M | 348.03M | 374.87M | 240.83M | 272.15M | 291.38M | 316.92M | 173.58M | 199.09M | 165.45M | 152.41M | 168.2M | 188.11M | 204.89M | 130.01M | 140.94M |
Account Payables | 4.54M | 4.97M | 4.28M | 3.65M | 3.11M | 2.12M | 2.37M | 3.2M | 3.39M | 2.77M | 2.91M | 2.71M | 3.1M | 2.89M | 1.76M | 5.07M | 3.55M | 3.57M |
Deferred Revenue | 7.7M | 10.27M | 11.7M | 9.93M | 10.7M | 10.44M | 10.14M | 15.21M | 19.21M | n/a | 3.87M | 5.93M | 8.17M | 10.87M | 11.41M | 11.97M | 11.75M | 11.38M |
Short-Term Debt | 6.29M | n/a | n/a | 3.9M | 13.95M | 6.8M | 6.59M | 5.49M | 4.21M | n/a | 3.68M | 1.79M | 1.75M | 1.7M | 1.65M | 1.62M | 1.57M | n/a |
Other Current Liabilities | 17.34M | 2.22M | 6.92M | 1.15M | 3.67M | 6.56M | 2.66M | 879K | 868K | 435K | 1.11M | 2.45M | 871K | 313K | 2.27M | 918K | 1.07M | 1.76M |
Total Current Liabilities | 31.32M | 29.82M | 35.96M | 28.66M | 38.57M | 31.48M | 29.82M | 33.15M | 35.12M | 14.05M | 17.3M | 16.59M | 17.17M | 18.46M | 21.34M | 22.94M | 20.62M | 18.84M |
Long-Term Debt | 58.12M | 32.18M | 32.07M | 30.65M | 20.11M | 23.45M | 26.7M | 28.84M | 29.72M | 29.5M | 29.29M | 29.07M | n/a | n/a | n/a | n/a | n/a | -159.41M |
Other Long-Term Liabilities | 32.41M | 124K | 135K | 146K | n/a | n/a | n/a | 12K | 24K | 36K | 49K | 97K | 97K | 97K | 97K | 236K | 238K | -159.17M |
Total Long-Term Liabilities | 90.53M | 92.69M | 94.19M | 90.28M | 81.08M | 86.39M | 91.46M | 89.27M | 91.2M | 81.51M | 82.35M | 32.2M | 3.59M | 4.04M | 5.99M | 7.87M | 169.42M | 172.02M |
Total Liabilities | 121.85M | 122.51M | 130.15M | 118.94M | 119.65M | 117.86M | 121.28M | 122.42M | 126.32M | 95.56M | 99.66M | 48.8M | 20.76M | 22.51M | 27.33M | 30.82M | 190.04M | 190.86M |
Total Debt | 64.4M | 97.04M | 97.38M | 90.36M | 91.07M | 91.76M | 92.43M | 86.98M | 87.74M | 85.31M | 85.98M | 33.9M | 5.24M | 5.65M | 6.04M | 6.41M | 6.79M | 7.15M |
Common Stock | 5K | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 1K | 1K |
Retained Earnings | -446.18M | -409.22M | -375.1M | -339.29M | -309.4M | -277.74M | -247.6M | -227.98M | -204.99M | -180.94M | -158.38M | -139.66M | -123.41M | -108.31M | -92.16M | -77.96M | -62.12M | -51.45M |
Comprehensive Income | -4K | -4K | 51K | n/a | n/a | -0.00 | n/a | 0.00 | n/a | n/a | -0.00 | 0.00 | n/a | n/a | 0.00 | -204.89M | -159.41M | 0.00 |
Shareholders Equity | 176.71M | 210.2M | 240.97M | 229.09M | 255.22M | 122.97M | 150.87M | 168.96M | 190.61M | 78.02M | 99.43M | 116.66M | 131.65M | 145.69M | 160.78M | 174.07M | -60.03M | -49.92M |
Total Investments | n/a | 97.58M | 111.42M | 138M | 55.52M | 27.3M | 63.72M | 60.23M | 5.03M | 5.03M | 5.04M | n/a | 5.04M | 5.03M | 5.2M | 595K | 595K | 761K |